Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
172.65    -0.75 (-0.43%)
Bid:
172.55
Ask:
172.65
Spread: 0.10 (0.058%)
Market Cap: £7.82b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Centrica announces nuclear life extensions

4 Dec 2024 07:00

RNS Number : 6866O
Centrica PLC
04 December 2024
 

4 December 2024

Centrica plc

 

Centrica announces extension to the lives of four nuclear power stations

Centrica plc (the "Company") is pleased to announce the extension of the lives of its four operational Advanced Gas-cooled Reactor ("AGR") nuclear power stations alongside its partner, EDF.

Heysham 1 and Hartlepool are now expected to generate electricity until March 2027, one year later than previously expected. And Heysham 2 and Torness have been extended by two years and are now expected to generate until March 2030. These extensions are expected to add around 9 TWh to the Company's electricity generation volumes between 2026 and 2030.*

The extensions will support the UK's baseload power generation for years to come, support the UK's net zero ambitions and help maintain grid stability at a time when cleaner, but more intermittent, renewable generation is being added to the energy mix.

Chris O'Shea, Centrica Group Chief Executive said: 

"At a time when energy security is uppermost in people's mind, I'm delighted that we're able to extend the operating window of the UK's nuclear fleet, which is critical to UK security of supply and the country's net zero ambitions. In an energy system that is becoming ever more intermittent, baseload power generation that doesn't depend on the sun shining and the wind blowing is essential to keeping the lights on. Today's extensions to the lives of the zero carbon Heysham 1, Heysham 2, Hartlepool and Torness nuclear power stations are a positive reflection of the valuable investment that Centrica and EDF have made in these plants.

"There is no silver bullet that will achieve net zero, but a diversified energy system underpinned by nuclear power is a positive further step towards a greener, fairer future. We're delighted that a further extension was possible which allows us the time necessary to develop other zero carbon dispatchable electricity generation options such as new nuclear and hydrogen fired generation. We must move at a faster pace to ensure that these replacement technologies are deployed in time."

The decision was taken after a detailed review process which sought to ensure that the lifetime of the power stations can be extended without compromising safety. The possibility of additional extensions would be subject to the outcome of further reviews, and any new decisions would be communicated publicly. 

ENDS

*Notes to Editors

· These extensions are expected to add 45TWh total, or 9TWh at Centrica's 20% share.

· This latest lifetime extension is the most likely view.

· These dates are forecasts, and the precise dates will be determined by the results of regular graphite inspections and how those results are interpreted by the operator, and by the independent regulator, the Office for Nuclear Regulation. 

· End of generation dates are kept under review and revised based on the best information available at the time. 

· Decisions on end of generation dates for nuclear power stations in the UK are independent of the regulator or government and are taken by the licensee board following recommendations. They are then endorsed by relevant senior Boards and, if needed, shareholders. 

· The decision on the change of generation dates for the four stations was taken following a series of executive, board and shareholder meetings on 3 December 2024. 

· Heysham 2 and Torness were due to move into defueling in March 2028 based on a review in 2021. 

· Heysham 1 and Hartlepool power stations were due to move into defueling in March 2026 based on a review in 2023. 

· The results of inspections of the graphite cores during 2024 have supported the decision to extend station lifetimes. 

· Sizewell B is a different type of nuclear power station, and its lifetime was not reviewed as part of this process. There is also a good opportunity to extend the lifetime of the Sizewell B station for a further 20 years, out to 2055. This will require securing a sustainable commercial model before an investment decision is taken. 

Enquiries:

Investors and AnalystsT: 01753 494900E: ir@centrica.com

MediaT: 01784 843000E: media@centrica.com

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFILFVLVIIS
Date   Source Headline
11th Jun 20262:00 pmRNSDirector/PDMR Shareholding
1st Jun 20263:45 pmRNSTotal Voting Rights
26th May 202612:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
18th May 20264:00 pmRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSBritish Gas agrees PPM settlement
14th May 20264:42 pmRNSPublication of a Prospectus
12th May 20263:15 pmRNSDirector/PDMR Shareholding
12th May 202612:15 pmRNSDirector/PDMR Shareholding
12th May 20267:10 amRNSDirectorate change
7th May 202612:15 pmRNSResult of AGM
7th May 20267:00 amRNSAcquisition of the Severn CCGT for c.£370 million
7th May 20267:00 amRNSAGM Statement
1st May 20262:30 pmRNSTotal Voting Rights
27th Apr 20262:30 pmRNSDirector/PDMR Shareholding
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 202612:00 pmRNSTotal Voting Rights
31st Mar 202610:33 amRNSNotice of AGM
25th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:15 pmRNSTotal Voting Rights
25th Feb 20265:15 pmRNSDirector/PDMR Shareholding
19th Feb 20262:39 pmRNSAnnual Financial Report 2025
19th Feb 20267:10 amRNSDirectorate change
19th Feb 20267:00 amRNSPreliminary Results
11th Feb 20265:30 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSCentrica announces divestments
2nd Feb 20263:00 pmRNSTotal Voting Rights
26th Jan 20264:15 pmRNSDirector/PDMR Shareholding
13th Jan 20263:00 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:09 pmRNSTransaction in Own Shares - Replacement
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.